Laura
L.
Hammitt
,
MD

Professor
Laura Hammitt

Departmental Affiliations

International Health
Primary
Division
Global Disease Epidemiology and Control

Center & Institute Affiliations

Research Profile View Current Courses

Contact Info

415 N. Washington Street, 4th Floor
Baltimore
Maryland
21231
US        
410-955-6931
lhammitt@jhu.edu
Experiences & Accomplishments
Education
MD
University of Utah
1999
BSc
University of Utah
1995
Select Publications

Most recent publications

    Hammitt LL, Crane R, Karani A, Mutuku A, Morpeth SC, Soctt JAG. Invasive Haemophilus influenzae type b (Hib) disease, nasopharyngeal carriage and population immunity in the decade following introduction of Hib vaccine in Kilifi, Kenya. Lancet Glob Health 2016. http://dx.doi.org/10.1016/S2214-109X(15)00316-2.

    Muema D, Nduati E, Uyoga M, Bashraheil M, Scott JAG, Hammitt LL, Urban B. 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine induces memory-B cell responses in healthy Kenyan toddlers. Clinical and Experimental Immunology 2015; 181:297-305.

    Faezel LM, Santorico SA, Robertson CE, Bashraheil M, Scott JAG, Frank DN, Hammitt LL. Effects of vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein-D conjugate vaccine on the nasopharyngeal microbiome of Kenyan toddlers. PLoS ONE 2015; 10: e0128064.

  • Wu Z, Deloria-Knoll M, Hammitt LL, Zeger SL and the Pneumonia Etiology Research for Child Health Core Team. Partially latent class models for case–control studies of childhood pneumonia aetiology. Journal of the Royal Statisitical Society: Series C (Applied Statisitics) 2015; doi:10.1111/rssc.12101

  • Hammitt LL, Akech DO, Morpeth SC, Karani A, Kihuha N, Nyongesa S, Bwanaali T, Mumbo E, Kamau T, Sharif SK, Scott JAG. Population impact of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya. Lancet Glob Health 2014; 2:e397-405.

See all publications by Laura L. Hammitt
Projects
Forecasting pneumococcal serotype frequencies to develop adult-specific vaccines
A phase II, double-blind, randomized, placebo controlled study to demonstrate the protective efficacy of GlaxoSmithKline (GSK) Biologicals’ Streptococcus pneumoniae protein vaccine against acute otitis media when administered as a three-dose primary...
Etiology of pneumonia and burden of pneumococcal pneumonia in hospitalized American Indian adults
Identifying persistent vaccine-type invasive pneumococcal disease and carriage in American Indian communities during routine use of PCV13
Evaluating Maternal Immunization
Impact of prevention of RSV-associated serious respiratory illness in infancy on asthma in childhood: The RSV Prevention part II Study (RSVpII)
RSV Suveillance in Native Americans (RSV SuNA)
Developing Bayesian analytical approaches to estimation of pneumonia etiology